Lang James Paul (CIK 1703090) reported 5 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-10). Recent activity: Buy OPRX (34,517 shares), Buy HALO (3,796 shares), Buy HALO (889 shares), Buy OPRX (9,868 shares), Buy OPRX (321,408 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-10 | OptimizeRx Corp (OPRX) | Director | Buy | 34,517 | $0 |
| 2026-05-07 | HALOZYME THERAPEUTICS, INC. (HALO) | Director | Buy | 3,796 | $0 |
| 2026-01-06 | HALOZYME THERAPEUTICS, INC. (HALO) | Director | Buy | 889 | $0 |
| 2025-06-12 | OptimizeRx Corp (OPRX) | Director | Buy | 9,868 | $0 |
| 2025-03-19 | OptimizeRx Corp (OPRX) | Director | Buy | 321,408 | $2.4M |
Source: SEC Form 4 filings · as of 2026-06-10